Relation of blood cadmium, lead, and mercury levels to biomarkers of lipid peroxidation in premenopausal women

American Journal of Epidemiology

Volumn 175, Issue 7, 2012, Pages 645-652

  Pollack, Anna Z ^a,b   Schisterman, Enrique F ^a   Goldman, Lynn R ^b   Mumford, Sunni L ^a   Perkins, Neil J ^a   Bloom, Michael S ^c   Rudra, Carole B ^d   Browne, Richard W ^d   Wactawski Wende, Jean ^d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY AT ALBANY   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cadmium; Hydroxyl octadecadienoic acid; Isoprostane; Lead; Mercury; Oxidative stress; Thiobarbituric acid reactive substances; Women

Indexed keywords

9 HYDROPEROXY 10,12 OCTADECADIENOIC ACID; CADMIUM; CORIOLIC ACID; HYDROXY FATTY ACID; ISOPROSTANE; LEAD; MERCURY; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

BIOACCUMULATION; BIOMARKER; BLOOD; CADMIUM; CARBOXYLIC ACID; CARDIOVASCULAR DISEASE; HEALTH IMPACT; LEAD; LIPID; MERCURY (ELEMENT); PLASMA; POLLUTION EXPOSURE; WOMENS HEALTH;

ADULT; ARTICLE; CALORIC INTAKE; FEMALE; FISH; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; LEAD BLOOD LEVEL; LIPID PEROXIDATION; MENSTRUAL CYCLE; NORMAL HUMAN; OXIDATIVE STRESS; PREMENOPAUSE; TRACE METAL BLOOD LEVEL;

ADOLESCENT; ADULT; ANIMALS; BIOLOGICAL MARKERS; CADMIUM; DIET; FEMALE; FISHES; HUMANS; ISOPROSTANES; LEAD; LINEAR MODELS; LINOLEIC ACIDS; LINOLEIC ACIDS, CONJUGATED; LIPID PEROXIDATION; MENSTRUAL CYCLE; MERCURY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; YOUNG ADULT;

NEW YORK [UNITED STATES]; UNITED STATES;

EID: 84859513113     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr375     Document Type: Article

References (52)

1. Centers for Disease Control and Prevention. Fourth National Report on Human Exposure to Environmental Chemicals. Atlanta, GA: Centers for Disease Control and Prevention; 2009.
2. Bazan NG, Colangelo V, Lukiw WJ. Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat. 2002;68-69:197-210. (Pubitemid 35247397)
3. Ikizler TA, Morrow JD, Roberts LJ, et al. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol. 2002;58(3):190-197. (Pubitemid 34994045)
4. Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004;65(3):1009-1016. (Pubitemid 38251077)
5. Goldman LR, Shannon MW. Technical report: mercury in the environment: implications for pediatricians. Pediatrics. 2001;108(1):197-205. (Pubitemid 32592029)
6. Vahter M, Berglund M, Akesson A, et al. Metals and women's health. Environ Res. 2002;88(3):145-155. (Pubitemid 34506240)
7. Mijal RS, Holzman CB. Blood cadmium levels in women of childbearing age vary by race/ethnicity. Environ Res. 2010;110(5):505-512.
8. Lee MG, Chun OK, Song WO. Determinants of the blood lead level of US women of reproductive age. J Am Coll Nutr. 2005;24(1):1-9. (Pubitemid 40558255)
9. Mahaffey KR, Clickner RP, Bodurow CC. Blood organic mercury and dietary mercury intake: National Health and Nutrition Examination Survey, 1999 and 2000. Environ Health Perspect. 2004;112(5):562-570. (Pubitemid 38500046)
10. Staessen J, Bruaux P, Claeys-Thoreau F, et al. The relationship between blood pressure and environmental exposure to lead and cadmium in Belgium. Environ Health Perspect. 1988;78(6):127-129.
11. Yazbeck C, Thiebaugeorges O, Moreau T, et al. Maternal blood lead levels and the risk of pregnancy-induced hypertension: the EDEN Cohort Study. Environ Health Perspect. 2009;117(10):1526-1530.
12. Navas-Acien A, Guallar E, Silbergeld EK, et al. Lead exposure and cardiovascular disease - a systematic review. Environ Health Perspect. 2007;115(3):472-482. (Pubitemid 46554449)
13. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320(14):915-924. (Pubitemid 19101597)
14. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med. 1995;18(2):321-336.
15. Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem. 2001;1(6):529-539.
16. Galanis A, Karapetsas A, Sandaltzopoulos R. Metal-induced carcinogenesis, oxidative stress and hypoxia signalling. Mutat Res. 2009;674(1-2):31-35.
17. Basu S. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal. 2008;10(8):1405- 1434.
18. Schisterman EF, Gaskins AJ, Mumford SL, et al. Influence of endogenous reproductive hormones on F2-isoprostane levels in premenopausal women: the BioCycle Study. Am J Epidemiol. 2010;172(4):430-439.
19. Karowicz-Bilinska A, Plodzidym M, Krol J, et al. Changes of markers of oxidative stress during menstrual cycle. Redox Rep. 2008;13(5):237-240.
20. Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of Oxidative Stress Study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med. 2005;38(6):711-718. (Pubitemid 40249741)
21. Milne GL, Yin H, Brooks JD, et al. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol. 2007;433:113-126.
22. Jira W, Spiteller G, Carson W, et al. Strong increase in hydroxy fatty acids derived from linoleic acid in human low density lipoproteins of atherosclerotic patients. Chem Phys Lipids. 1998;91(1):1-11. (Pubitemid 28056877)
23. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med. 1990;9(6):515-540. (Pubitemid 120036914)
24. Wactawski-Wende J, Schisterman EF, Hovey KM, et al. BioCycle Study: design of the longitudinal study of the oxidative stress and hormone variation during the menstrual cycle. Paediatr Perinat Epidemiol. 2009;23(2):171-184.
25. Howards PP, Schisterman EF, Wactawski-Wende J, et al. Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study. Am J Epidemiol. 2009;169(1):105-112.
26. Schisterman EF, Vexler A, Whitcomb BW, et al. The limitations due to exposure detection limits for regression models. Am J Epidemiol. 2006;163(4):374-383. (Pubitemid 43238432)
27. Browne RW, Bloom MS, Schisterman EF, et al. Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle. Biomarkers. 2008;13(2):160-183. (Pubitemid 351250364)
28. Milne GL, Sanchez SC, Musiek ES, et al. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc. 2007;2(1):221-226. (Pubitemid 47040087)
29. Browne RW, Armstrong D. HPLC analysis of lipid-derived polyunsaturated fatty acid peroxidation products in oxidatively modified human plasma. Clin Chem. 2000;46(6):829-836. (Pubitemid 30397447)
30. Browne RW, Armstrong D. Simultaneous determination of polyunsaturated fatty acids and corresponding monohydroperoxy and monohydroxy peroxidation products by HPLC. Methods Mol Biol. 2002;186:13-20.
31. Armstrong D, Browne R. The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv Exp Med Biol. 1994;366:43-58.
32. Browne RW, Bloom MS, Schisterman EF, et al. Analytical and biological variation of F2-isoprostanes during the menstrual cycle. Clin Chem. 2009;55(6):1245-1247.
33. Craig CL, Marshall AL, Sjöström M, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-1395. (Pubitemid 36936159)
34. Spearman C. The proof and measurement of association between two things. By C. Spearman, 1904. Am J Psychol. 1987;100(3-4):441-471.
35. Songdej N, Winters PC, McCabe MJ Jr, et al. A population-based assessment of blood lead levels in relation to inflammation. Environ Res. 2010;110(3):272-277.
36. Kasperczyk A, Kasperczyk S, Horak S, et al. Assessment of semen function and lipid peroxidation among lead exposed men. Toxicol Appl Pharmacol. 2008;228(3):378-384.
37. Jiun YS, Hsien LT. Lipid peroxidation in workers exposed to lead. Arch Environ Health. 1994;49(4):256-259.
38. Kasperczyk S, Kasperczyk A, Ostalowska A, et al. Activity of glutathione peroxidase, glutathione reductase, and lipid peroxidation in erythrocytes in workers exposed to lead. Biol Trace Elem Res. 2004;102(1-3):61-72. (Pubitemid 40105007)
39. Devi SS, Biswas AR, Biswas RA, et al. Heavy metal status and oxidative stress in diesel engine tuning workers of central Indian population. J Occup Environ Med. 2007;49(11):1228-1234. (Pubitemid 350098678)
40. Muntner P, Menke A, DeSalvo KB, et al. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med. 2005;165(18):2155-2161. (Pubitemid 41434593)
41. Schober SE, Sinks TH, Jones RL, et al. Blood mercury levels in US children and women of childbearing age, 1999-2000. JAMA. 2003;289(13):1667-1674. (Pubitemid 37430272)
42. Nälsén C, Vessby B, Berglund L, et al. Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2α in healthy humans. J Nutr. 2006;136(5):1222-1228.
43. Mahaffey KR, Clickner RP, Jeffries RA. Adult women's blood mercury concentrations vary regionally in the United States: association with patterns of fish consumption (NHANES 1999-2004). Environ Health Perspect. 2009;117(1):47-53.
44. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296(15):1885-1899. (Pubitemid 44596197)
45. Berntssen MH, Aatland A, Handy RD. Chronic dietary mercury exposure causes oxidative stress, brain lesions, and altered behaviour in Atlantic salmon (Salmo salar) parr. Aquat Toxicol. 2003;65(1):55-72. (Pubitemid 37025653)
46. Archer KJ, Dumur CI, Taylor GS, et al. A disattenuated correlation estimate when variables are measured with error: illustration estimating cross-platform correlations. Stat Med. 2008;27(7):1026-1039. (Pubitemid 351395461)
47. Trichopoulou A, Costacou T, Bamia C, et al. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348(26):2599-2608. (Pubitemid 36741587)
48. Pollack AZ, Schisterman EF, Goldman LR, et al. Cadmium, lead, and mercury in relation to reproductive hormones and anovulation in premenopausal women. Environ Health Perspect. 2011;119(8):1156-1161.
49. Kaufman S, Kaufman JS, MacLehose RF, et al. Improved estimation of controlled direct effects in the presence of unmeasured confounding of intermediate variables. Stat Med. 2005;24(11):1683-1702. (Pubitemid 40754088)
50. Basu S, Eriksson M. Lipid peroxidation induced by an early inflammatory response in endotoxaemia. Acta Anaesthesiol Scand. 2000;44(1):17-23. (Pubitemid 30016642)
51. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 1995;332(18):1198-1203.
52. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752-1761. (Pubitemid 40385531)